Literature DB >> 26273060

Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromes.

Aziz Nazha1, David Seastone1, Tom Radivoyevitch2, Bartlomiej Przychodzen2, Hetty E Carraway1, Bhumika J Patel2, Jennifer Carew2, Hideki Makishima2, Mikkael A Sekeres1, Jaroslaw P Maciejewski3.   

Abstract

Entities:  

Keywords:  MDS; hypoplastic; mutations

Mesh：

Year:  2015        PMID： 26273060      PMCID： PMC4825290          DOI： 10.3324/haematol.2015.130112

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Clonal architecture of secondary acute myeloid leukemia.

Authors:  Matthew J Walter; Dong Shen; Li Ding; Jin Shao; Daniel C Koboldt; Ken Chen; David E Larson; Michael D McLellan; David Dooling; Rachel Abbott; Robert Fulton; Vincent Magrini; Heather Schmidt; Joelle Kalicki-Veizer; Michelle O'Laughlin; Xian Fan; Marcus Grillot; Sarah Witowski; Sharon Heath; John L Frater; William Eades; Michael Tomasson; Peter Westervelt; John F DiPersio; Daniel C Link; Elaine R Mardis; Timothy J Ley; Richard K Wilson; Timothy A Graubert
Journal:  N Engl J Med       Date:  2012-03-14       Impact factor: 91.245

Review 2.  Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to success.

Authors:  Elaine M Sloand; A J Barrett
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

Review 3.  Immunologic aspects of hypoplastic myelodysplastic syndrome.

Authors:  Rodrigo T Calado
Journal:  Semin Oncol       Date:  2011-10       Impact factor: 4.929

4.  Clinical effect of point mutations in myelodysplastic syndromes.

Authors:  Rafael Bejar; Kristen Stevenson; Omar Abdel-Wahab; Naomi Galili; Björn Nilsson; Guillermo Garcia-Manero; Hagop Kantarjian; Azra Raza; Ross L Levine; Donna Neuberg; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2011-06-30       Impact factor: 91.245

5.  SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.

Authors:  Manuel G Afable; Marcin Wlodarski; Hideki Makishima; Mohammed Shaik; Mikkael A Sekeres; Ramon V Tiu; Matt Kalaycio; Christine L O'Keefe; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

6.  Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes.

Authors:  S Yazji; F J Giles; A-M Tsimberidou; E H Estey; H M Kantarjian; S A O'Brien; R Kurzrock
Journal:  Leukemia       Date:  2003-11       Impact factor: 11.528

Review 7.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

8.  Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies.

Authors:  T-C Huang; B-S Ko; J-L Tang; C Hsu; C-Y Chen; W Tsay; S-Y Huang; M Yao; Y-C Chen; M-C Shen; C-H Wang; H-F Tien
Journal:  Leukemia       Date:  2007-12-20       Impact factor: 11.528

Review 9.  Hypocellular myelodysplasia.

Authors:  Elaine M Sloand
Journal:  Hematol Oncol Clin North Am       Date:  2009-04       Impact factor: 3.722

10.  Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.

Authors:  Li Ding; Timothy J Ley; David E Larson; Christopher A Miller; Daniel C Koboldt; John S Welch; Julie K Ritchey; Margaret A Young; Tamara Lamprecht; Michael D McLellan; Joshua F McMichael; John W Wallis; Charles Lu; Dong Shen; Christopher C Harris; David J Dooling; Robert S Fulton; Lucinda L Fulton; Ken Chen; Heather Schmidt; Joelle Kalicki-Veizer; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Michael C Wendl; Sharon Heath; Mark A Watson; Daniel C Link; Michael H Tomasson; William D Shannon; Jacqueline E Payton; Shashikant Kulkarni; Peter Westervelt; Matthew J Walter; Timothy A Graubert; Elaine R Mardis; Richard K Wilson; John F DiPersio
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962
View more
  10 in total

Review 1.  Recent advances in understanding clonal haematopoiesis in aplastic anaemia.

Authors:  Natasha Stanley; Timothy S Olson; Daria V Babushok
Journal:  Br J Haematol       Date:  2017-01-20       Impact factor: 6.998

2.  Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome.

Authors:  Jibran Durrani; Jaroslaw P Maciejewski
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

3.  Outcome of allogeneic hematopoietic stem cell transplantation for hypoplastic myelodysplastic syndrome.

Authors:  Ming Zhou; Liangliang Wu; Yuping Zhang; Wenjian Mo; Yumiao Li; Xiaowei Chen; Caixia Wang; Shiyi Pan; Shilin Xu; Wei Zhou; Tingfen Deng; Shunqing Wang
Journal:  Int J Hematol       Date:  2020-08-16       Impact factor: 2.490

Review 4.  The clinical and laboratory evaluation of patients with suspected hypocellular marrow failure.

Authors:  Siobán Keel; Amy Geddis
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 5.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Authors:  Joseph D Khoury; Eric Solary; Oussama Abla; Yassmine Akkari; Rita Alaggio; Jane F Apperley; Rafael Bejar; Emilio Berti; Lambert Busque; John K C Chan; Weina Chen; Xueyan Chen; Wee-Joo Chng; John K Choi; Isabel Colmenero; Sarah E Coupland; Nicholas C P Cross; Daphne De Jong; M Tarek Elghetany; Emiko Takahashi; Jean-Francois Emile; Judith Ferry; Linda Fogelstrand; Michaela Fontenay; Ulrich Germing; Sumeet Gujral; Torsten Haferlach; Claire Harrison; Jennelle C Hodge; Shimin Hu; Joop H Jansen; Rashmi Kanagal-Shamanna; Hagop M Kantarjian; Christian P Kratz; Xiao-Qiu Li; Megan S Lim; Keith Loeb; Sanam Loghavi; Andrea Marcogliese; Soheil Meshinchi; Phillip Michaels; Kikkeri N Naresh; Yasodha Natkunam; Reza Nejati; German Ott; Eric Padron; Keyur P Patel; Nikhil Patkar; Jennifer Picarsic; Uwe Platzbecker; Irene Roberts; Anna Schuh; William Sewell; Reiner Siebert; Prashant Tembhare; Jeffrey Tyner; Srdan Verstovsek; Wei Wang; Brent Wood; Wenbin Xiao; Cecilia Yeung; Andreas Hochhaus
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

Review 6.  Aplastic Anemia.

Authors:  Neal S Young
Journal:  N Engl J Med       Date:  2018-10-25       Impact factor: 91.245

Review 7.  Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome?

Authors:  Bruno Fattizzo; Fabio Serpenti; Wilma Barcellini; Chiara Caprioli
Journal:  Cancers (Basel)       Date:  2021-01-03       Impact factor: 6.639

8.  Distinctive and common features of moderate aplastic anaemia.

Authors:  Bhumika J Patel; Shimoli V Barot; Teodora Kuzmanovic; Cassandra Kerr; Bartlomiej P Przychodzen; Swapna Thota; Sarah Lee; Saurabh Patel; Tomas Radivoyevitch; Alan Lichtin; Anjali Advani; Matt Kalaycio; Mikkael A Sekeres; Hetty E Carraway; Jaroslaw P Maciejewski
Journal:  Br J Haematol       Date:  2020-01-31       Impact factor: 8.615

9.  Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).

Authors:  Chi-Yuan Yao; Hsin-An Hou; Tzung-Yi Lin; Chien-Chin Lin; Wen-Chien Chou; Mei-Hsuan Tseng; Ying-Chieh Chiang; Ming-Chih Liu; Chia-Wen Liu; Yuan-Yeh Kuo; Shang-Ju Wu; Xiu-Wen Liao; Chien-Ting Lin; Bor-Shen Ko; Chien-Yuan Chen; Szu-Chun Hsu; Chi-Cheng Li; Shang-Yi Huang; Ming Yao; Jih-Luh Tang; Woei Tsay; Chieh-Yu Liu; Hwei-Fang Tien
Journal:  Oncotarget       Date:  2016-09-27

Review 10.  Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune‑mediated bone marrow failure syndromes (Review).

Authors:  Hana Votavova; Monika Belickova
Journal:  Int J Oncol       Date:  2021-12-27       Impact factor: 5.650
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.